Catalyst Wire Dossier Catalyst Wire Dossier

d-Amphetamine Transdermal System

d-amphetamine transdermal system · Noven Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for d-Amphetamine Transdermal System, covering 2023-12-21 to 2023-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD [Phase 2]

See pricing